Have a personal or library account? Click to login
Clinical Impact and Relevance of Antiganglioside Antibodies Test Results / Antigangliozīdu Antivielu Testa Rezultātu Klīniskā Ietekme un Nozīme Pacientam
Kusunoki, S., Kaida, K., Ueda, M. (2008). Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: New aspects of research. Biochim. Biophys. Acta, 1780, 441-44410.1016/j.bbagen.2007.10.00117976386
Logina, I., Ķēniņa, V., Kurjāne, N., Gudreniece, A., Noviks, I. (2014). Autoimūno nervu sistēmas slimību klīniskās vadlīnijas [Clinical guidelines for neurologic autoimmune diseases]. Latvijas Neiroimunologu asociācija. Rīga. 81 lpp. (in Latvian).
Rojas-Garcia, R., Querol, L., Gallardo, E., De Luna Salva, N., Juarez, C., Garces, M., Fages, E., Casasnovas, C., Illa, I. (2012). Clinical and serological features of acute sensory ataxic neuropathy with antiganglioside antibodies. J. Periph. Nerv. Syst., 17, 158-168.10.1111/j.1529-8027.2012.00407.x22734901
Sejvar, J. J., Baughman, A. L., Wise, M., Morgan, O. W. (2011). Population incidence of Guillain-Barré Syndrome: A systematic review and metaanalysis. Neuroepidemiology, 36, 123-133.10.1159/000324710570304621422765
Tatsumoto, M., Koga, M., Gilbert, M., Odaka, M., Hirata, K., Kuwabara, S., Yuki, N. (2006). Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a. J. Neuroimmunol., 177 (1-2), 201-208.10.1016/j.jneuroim.2006.04.00516844234
Yu, R. K., Usuki, S., Ariga, T. (2006), Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases. Infect Immun., 74 (12), 6517-6527. 10.1128/IAI.00967-06169809216966405